ARTICLE | Clinical News
TOBI Podhaler regulatory update
July 16, 2012 7:00 AM UTC
FDA's Anti-Infectives Drugs Advisory Committee will meet on Sept. 5 to discuss an NDA from Novartis for TOBI Podhaler to treat Pseudomonas aeruginosa lung infections in cystic fibrosis patients. Novar...